Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 4 Medulloblastoma 3 Choroid Plexus Neoplasms 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Pinealoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive 2 Meningioma 2 Gliosarcoma 2 Glioma, Subependymal 2 Glioma 2 Glioblastoma 2 Fatigue 2 Ependymoma 2 Depression 2 Craniopharyngioma 2 Cognitive Dysfunction 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Retention 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Pain 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Morphine 16 Oxycodone 14 Fentanyl 10 Methadone 7 nabiximols 5 Lidocaine 5 Acetaminophen 5 resiniferatoxin 4 Hydromorphone 4 Ethanol 4 Acupuncture Therapy 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Transcranial Direct Current Stimulation 2 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiosurgery 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Naloxone 2 Ketamine 2 Electroacupuncture 2 Dronabinol 2 Control Groups 2 Analgesics, Opioid 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tanezumab 1 rofecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × Donepezil × Clear all

NCT00352664 2016-05-09

The Effect of Donepezil on Sedation and Other Symptoms

M.D. Anderson Cancer Center

Phase 3 Terminated

27 enrolled 2 charts

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡